米国の使い捨て病院用品市場見通し（～2021）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Disposable Hospital Supplies Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10
3 Disposable Hospital Supplies Market, United States 11
3.1 Disposable Hospital Supplies Market, United States, Revenue ($m), 2007-2014 11
3.2 Disposable Hospital Supplies Market, United States, Revenue ($m), 2014-2021 13
3.3 Disposable Hospital Supplies Market, United States, Volume (Units), 2007-2014 15
3.4 Disposable Hospital Supplies Market, United States, Volume (Units), 2014-2021 17
3.5 Disposable Hospital Supplies Market, United States, Average Price ($), 2007-2021 19
3.6 Disposable Hospital Supplies Market, United States, Distribution Share by Revenue ($m), 2013-2014 21
3.7 Disposable Hospital Supplies Market, United States, Company Share by Revenue ($m), 2014 22
4 Overview of Key Companies in United States, Disposable Hospital Supplies Market 24
4.1 Cardinal Health, Inc. 24
4.1.1 Company Overview 24
4.2 3M Health Care Ltd. 24
4.2.1 Company Overview 24
4.3 Halyard Health, Inc. 24
4.3.1 Company Overview 24
4.4 Medline Industries, Inc. 25
4.4.1 Company Overview 25
4.5 Molnlycke Health Care AB 25
4.5.1 Company Overview 25
4.6 Covidien plc 25
4.6.1 Company Overview 25
5 Financial Deals Landscape 26
5.1 Acquisition 26
5.1.1 Stryker to Acquire Sage Products from Madison Dearborn Partners for USD2.8 Billion 26
5.1.2 NN Completes Acquisition of Precision Engineered Products from Jordan Company and Nautic Partners for USD615 Million 28
5.1.3 Danaher Acquires Pall for USD13.8 Billion 30
5.1.4 Cardinal Health Acquires Metro Medical Supply 32
5.2 Debt Offerings 33
5.2.1 Invacare Prices Private Placement of 5% Notes Due 2021 for USD130 Million 33
5.3 Equity Offerings 35
5.3.1 Integra LifeSciences Raises USD220 Million in Public Offering of Shares 35
5.3.2 Integra LifeSciences Prices Public Offering of Shares for USD201.3 Million 36
5.4 Private Equity 38
5.4.1 Third Point Acquires 7% Stake in Baxter International 38
5.5 Venture Financing 39
5.5.1 Vestagen Technical Textiles Raises USD7 Million in Venture Financing 39
5.5.2 Eccrine Systems Raises USD1.5 Million in Seed Financing 40
6 Recent Developments 41
6.1 Corporate Communications 41
6.1.1 Jan 13, 2016: Command Medical Products Hires John Walter as Director of New Business Development 41
6.1.2 Nov 20, 2015: Marc Gibeley Joins Board of Directors of Invacare 41
6.1.3 Oct 28, 2015: SteadyMed Announces Positive Clinical Study Results in Support of SMT-201 for the Treatment of Post Surgical Pain in the Home Setting 42
6.1.4 Oct 28, 2015: Baxter Names José Almeida Chairman and CEO 43
6.1.5 Oct 27, 2015: Baxter To Reduce Workforce 44
6.1.6 Oct 26, 2015: Michael Bruch Appointed Chief Financial Officer of Cesca Therapeutics 44
6.1.7 Oct 21, 2015: Baxter Appoints Michael F. Mahoney to Its Board 44
6.1.8 Oct 15, 2015: Actinium Announces Completion of the Fourth and Final Cohort of Its Actimab-A Trial 45
6.1.9 Sep 30, 2015: Baxter Appoints Munib Islam to Board; Announces Agreement with Third Point 45
6.1.10 Sep 29, 2015: Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences 46
6.1.11 Sep 28, 2015: Ken Harris to Step Down as President of Cesca Therapeutics 47
6.1.12 Sep 15, 2015: Cesca Therapeutics Announces Restructuring Initiative 47
6.1.13 Sep 11, 2015: Owens & Minor Names W. Marshall Simpson as Executive Vice President & Chief Commercial Officer 48
6.1.14 Aug 27, 2015: Spectranetics Names Stacy McMahan Chief Financial Officer 48
6.1.15 Jul 09, 2015: SonaCare Medical Sells Prostate Ablation System with MRI/Ultrasound Image Fusion to Heidelberg Prostate Clinic 49
6.1.16 Jun 19, 2015: Mal Mixon to Retire from Invacare Board of Directors 50
6.1.17 Jun 12, 2015: Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer 50
6.1.18 May 20, 2015: Owens & Minor Names P. Cody Phipps President & Chief Executive Officer, Effective July 1 50
6.1.19 May 14, 2015: Bellicum Announces Clinical Study Results Published in BLOOD and Featured in Late-Breaking Session at ASGCT Annual Meeting 51
6.1.20 May 14, 2015: Invacare Adds Two New Board Members 53
6.1.21 May 04, 2015: Cesca Therapeutics Announces Changes in Management 54
6.1.22 Apr 30, 2015: Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine 54
6.1.23 Mar 12, 2015: Spectranetics Appoints Todd C. Schermerhorn as Director 55
6.1.24 Mar 05, 2015: Study Shows Castle Biosciences’ Noninvasive Skin Melanoma Gene Test Improves Accuracy of Sentinel Lymph Node Biopsy in Predicting Metastasis 55
6.1.25 Mar 04, 2015: Hill-Rom Elects Stacy Enxing Seng to its Board of Directors 57
6.1.26 Mar 02, 2015: Alize Pharma launches Phase II clinical trial of AZP-531 in Prader-Willi syndrome 57
6.1.27 Feb 24, 2015: Command Medical Products Announces Executive Promotion 59
6.2 Financial Announcements 59
6.2.1 Feb 16, 2016: Cesca Therapeutics Reports Second Quarter Fiscal 2016 Results and Provides a Status Update to Investors 59
6.2.2 Feb 11, 2016: Invacare Announces Financial Results for the Quarter and Year Ended December 31, 2015 60
6.2.3 Feb 08, 2016: Owens & Minor Reports 4th Quarter & Full-Year 2015 Financial Results 67
6.2.4 Feb 02, 2016: Baxter Announces Fourth Quarter Results and Provides 2016 Financial Outlook 68
6.2.5 Feb 01, 2016: Hill-Rom Reports Strong First Quarter Results Exceeding Previous Guidance and Increases Full Year Earnings Outlook 70
6.2.6 Jan 27, 2016: Sharps Compliance Reports Record Customer Billings of $10.5 Million for the Second Quarter of Fiscal 2016 71
6.2.7 Jan 12, 2016: Hill-Rom Reports Preliminary Fiscal First Quarter Revenue 74
6.2.8 Dec 07, 2015: Leading HIFU Expert Begins U.S.-Based Program With Treatment Of First Prostate Cancer Patients 75
6.2.9 Nov 25, 2015: Pall Reports First Quarter Results 77
6.2.10 Nov 23, 2015: AdvanSource Biomaterials Reports Fiscal 2016 Second Quarter Results and Third Consecutive Quarterly Profit 78
6.2.11 Nov 16, 2015: Vigilant Biosciences Receives CE Mark for OncAlertTM Oral Cancer CD44/Total Protein LAB Test to Aid in Diagnosis of Oral Cancer 79
6.2.12 Nov 16, 2015: Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model 80
6.2.13 Nov 16, 2015: Cesca Therapeutics Reports First Quarter Fiscal Year 2016 Financial Results 82
6.2.14 Nov 15, 2015: ERBA to Launch LISA XL System in Europe and International Markets; Product to be Featured at MEDICA 2015 83
6.2.15 Nov 13, 2015: Lumenis Expands Its Portfolio of Gynecology Solutions with the New UltraPulse DUO for Fertility-Related Disorders and FemTouch for Improved Vaginal Health 85
6.2.16 Nov 12, 2015: In New Study EMMA Capnograph Has Comparable Accuracy to Sidestream Capnography Against Gold-Standard Blood Gas Analysis 87
6.2.17 Nov 05, 2015: Hill-Rom Reports Strong Fourth Quarter and Full-Year Results Exceeding Previous Guidance 88
6.2.18 Nov 03, 2015: Integra LifeSciences Reports Third Quarter 2015 Financial Results 90
6.2.19 Oct 30, 2015: Licensee’s drug to commence Phase 2 and Phase 3 trials 91
6.2.20 Oct 29, 2015: Neuren Completes Enrolment in “INTREPID” Clinical Trial 93
6.2.21 Oct 28, 2015: New Study Bolsters Cologuard’s Performance in Detecting Colorectal Cancer and Ability to Improve Access to Screening 93
6.2.22 Oct 28, 2015: Sharps Compliance Fiscal 2016 First Quarter Revenue Increases 12% to $7.9 Million 94
6.2.23 Oct 27, 2015: Baxter Reports Strong Third Quarter Financial Results Exceeding Previously Issued Guidance 96
6.2.24 Oct 27, 2015: Owens & Minor Releases 3rd Quarter 2015 Financial Results 98
6.2.25 Oct 22, 2015: Spectranetics Achieves Third Quarter 2015 Revenue of $61.7 Million 99
6.2.26 Oct 22, 2015: Invacare Announces Financial Results for the Third Quarter and Nine Months of 2015 100
6.2.27 Oct 15, 2015: ConvaTec: Third Quarter 2015 Report 105
6.2.28 Oct 08, 2015: Allergan To Present Data On Anti-Infective Drug AVYCAZ at IDWeek 2015 109
6.2.29 Sep 30, 2015: Zogenix Reports Positive Top-Line Results From Relday Phase 1b Multi-Dose Clinical Trial 110
6.2.30 Sep 29, 2015: Motif Announces Presentation of Two Posters on Iclaprim at ID Week 2015 112
6.2.31 Sep 17, 2015: Cesca Therapeutics Reports Fiscal Year 2015 Results 114
6.2.32 Aug 27, 2015: RedHill Biopharma Receives Notice of Allowance for New Israeli Patent Covering RHB-104 for the Treatment of Crohn’s Disease 115
6.2.33 Aug 20, 2015: AdvanSource Biomaterials Reports Fiscal 2016 First Quarter Results and Second Consecutive Quarterly Profit 117
6.2.34 Aug 12, 2015: Sharps Compliance Fiscal 2015 Fourth Quarter Revenue Increases 27% To $9.0 Million; Customer Billings Increase 28% to $9.4 Million 118
6.2.35 Aug 11, 2015: Command Medical Products Announces Promotion to Vice President 121
6.2.36 Aug 07, 2015: Hill-Rom Reports Strong Third Quarter Results; Updates 2015 Adjusted Earnings Outlook 121
6.2.37 Jul 30, 2015: Integra LifeSciences Reports Second Quarter 2015 Financial Results 123
6.2.38 Jul 29, 2015: Baxter Reports Strong Second Quarter Financial Results Exceeding Guidance 124
6.2.39 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results 126
6.2.40 Jul 27, 2015: Owens & Minor Releases 2nd Quarter 2015 Financial Results 127
6.2.41 Jul 23, 2015: Invacare Announces Financial Results for the Second Quarter and First Six Months of 2015 129
6.2.42 Jul 23, 2015: Spectranetics Reports Second Quarter Financial Results 133
6.2.43 Jul 15, 2015: Newest FDA-Cleared Breakthrough In Women’s Health Treatments Provided at the Healthcare Practice of Lizellen La Follette, MD 134
6.2.44 Jul 15, 2015: ConvaTec: Second Quarter 2015 Report 135
6.2.45 Jul 14, 2015: NorthShore University HealthSystem Becomes First in Illinois to Install Revolutionary Neurological Operating System 138
6.2.46 Jul 13, 2015: Study Demonstrates Accuracy of GlySure Continuous Intravascular Glucose Monitoring System in Critically Ill Patients 140
6.2.47 Jun 23, 2015: Cesca Therapeutics Reports Third Quarter Fiscal 2015 Results 142
6.2.48 May 21, 2015: Pall Reports Third Quarter Results 143
6.2.49 May 05, 2015: Hill-Rom Reports Second Quarter Results Ahead Of Guidance; Increases 2015 Adjusted Earnings Outlook 144
6.2.50 Apr 30, 2015: Integra LifeSciences Reports First Quarter 2015 Financial Results 145
6.2.51 Apr 28, 2015: Hospira Reports First-Quarter 2015 Results 146
6.2.52 Apr 27, 2015: Medtronic Announces Consent Decree with FDA for the Synchromed Drug Infusion System 148
6.2.53 Apr 27, 2015: Owens & Minor Reports 1st Quarter 2015 Financial Results 149
6.2.54 Apr 23, 2015: Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million 150
6.2.55 Apr 23, 2015: Invacare Announces Financial Results for the First Quarter of 2015 151
6.2.56 Apr 23, 2015: Baxter Reports First Quarter Financial Results That Exceed Guidance 154
6.2.57 Apr 16, 2015: Arch Therapeutics’ AC5 Compared Favorably vs. Commercially Available Combination Hemostat in Animal Study 155
6.2.58 Apr 15, 2015: ConvaTec: First Quarter 2015 Report 156
6.2.59 Apr 07, 2015: Positive Clinical Data for iCAD’s Xoft System to be Highlighted at American Brachytherapy Society Annual Meeting 159
6.2.60 Mar 30, 2015: BRILINTA receives US FDA approval for new administration option 160
6.2.61 Mar 06, 2015: TSO3 to showcase its STERIZONE VP4 Sterilizer at AORN Surgical Conference and Expo 2015 163
6.2.62 Mar 06, 2015: TSO3 Enters Into First Commercial Agreement For Sterizone Vp4 Sterilizer 165
6.2.63 Mar 04, 2015: Illumina Launches TruSight HLA Solution 166
6.2.64 Feb 25, 2015: NICE guidance recommends simeprevir for treating hepatitis C 169
6.2.65 Feb 24, 2015: Integra LifeSciences Reports Fourth Quarter 2014 Financial Results 170
6.3 Government and Public Interest 171
6.3.1 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 171
6.4 Legal And Regulatory 172
6.4.1 May 01, 2015: Hospira Statement On FDA’s Final Biosimilar Guidance Documents 172
6.4.2 Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant 173
6.4.3 Apr 13, 2015: Hope for Greater Access for Patients to Biosimilar Medicines 173
6.4.4 Feb 27, 2015: Hospira Provides Update On FDA Inspection At Its Facilities In US And India 174
6.5 Other Significant Developments 174
6.5.1 Jan 06, 2016: FONAR Management Subsidiary HMCA Adds 25th MRI Center 174
6.5.2 Dec 28, 2015: Tennessee Health Management Selects Medline as Exclusive Distribution Partner in $4 Million Prime Vendor Deal 175
6.5.3 Nov 17, 2015: Medline to Provide Robust Product Portfolio and Strategic Tools to More Than 200 Physician Offices Through New $9 Million Prime Vendor Agreement 176
6.5.4 Sep 28, 2015: Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes 176
6.5.5 Sep 15, 2015: Medline Secures Exclusive Distribution Partnership with OSF HealthCare in $250 Million Prime Vendor Deal 177
6.5.6 Sep 11, 2015: Pall Ilfracombe, UK Manufacturing Facility Wins Gold at the 2015 RoSPA Occupational Health and Safety Awards 178
6.5.7 Aug 25, 2015: Jhpiego and Johns Hopkins Center for Bioengineering Innovation & Design Selected as Finalist for 2015 INDEX: Award 178
6.5.8 Mar 30, 2015: Baxter Expands Access to Healthcare Through Collaborations and Charitable Giving 179
6.5.9 Mar 26, 2015: Medline to Provide American Academy of Orthopaedic Surgeons Members Significant Cost-Savings, Clinical and Quality Assurance Solutions through New Preferred Supplier Agreement 180
6.5.10 Mar 04, 2015: Hill-Rom Declares Second Quarter 2015 Dividend 181
6.6 Product News 181
6.6.1 Jan 26, 2016: Baxter initiates Voluntary Nationwide Recall of Select Lots of IV Solutions Due to the Potential for Leaking Containers and Particulate Matter 181
6.7 Strategy And Business Planning 182
6.7.1 Jan 14, 2016: Scrutiny of Essure Increases as Women Come Forward Claiming Permanent Injuries 182
6.7.2 Nov 12, 2015: Baxter Completes Capacity Expansion at Halle, Germany Facility to Support BioPharma Solutions’ Oncology Contract Manufacturing Services 183
6.7.3 Oct 15, 2015: Baxter International expanding operations in Mountain Home 184
6.7.4 Sep 28, 2015: Clinical Data Presented On Binimetinib And Encorafenib In Melanoma 185
6.7.5 Jul 07, 2015: PrenaTest is now reimbursed by Swiss statutory health insurance programs 187
6.7.6 Jul 01, 2015: Integra LifeSciences Completes Spin-Off of SeaSpine 188
6.7.7 May 18, 2015: Baxter and Baxalta Highlight Business Strategies at Investor Conference 188
6.7.8 Apr 01, 2015: Integra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine 190
7 Appendix 192
7.1 Research Methodology 193
7.1.1 Coverage 193
7.1.2 Secondary Research 193
7.1.3 Primary Research 193
7.1.4 Company Share Analysis 194
7.1.5 Distribution Share Analysis 194
7.2 GlobalData Consulting 194
7.3 Contact Us 194
7.4 Disclaimer 195